New ultrasound tool aims to improve hip replacement precision
NCT ID NCT03555812
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a portable ultrasound device that measures pelvic tilt, which is important for planning hip replacement surgery. Researchers will check how consistent the measurements are by repeating them on 3 healthy volunteers and then measure pelvic tilt in 30 patients before and after hip replacement. The goal is to see if the device works reliably in different positions and body types.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- navigated ultrasound device
- What this could lead to
- If successful, this device could help surgeons better plan hip replacements by providing reliable pelvic tilt measurements.
- What could go wrong
- This is a small, early-stage study focused on device accuracy, not treatment outcomes. It may not lead to improved surgical results or patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Jul 2018
- Finished
-
Jul 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For primary endpoint * No medical or surgical history * Major healthy voluntary topic with * Body Mass Index (BMI) \<20 for a subject * 24 \<BMI \<26 for a subject * BMI\> 30 for a subject * Subject having signed an informed consent For the secondary endpoint * Adult patient requiring total hip arthroplasty for severe hip osteoarthritis * Patient having signed an informed consent Exclusion Criteria: * Minor subject * Resumption of total hip prosthesis * Subject who can not express their consent to research * Presence of medical or surgical history for healthy volunteers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroplasty, replacement, hip are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brest University Hospital
Brest, 29609, France
-
Clinique de Keraudren
Brest, 29200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Antibiotic-Infused bone graft could slash infection risk in hip replacements
- Hip replacement patients may use fewer opioids with a simple change
- Fasting before hip surgery may cut infection risk, new trial hopes to prove
- Could a weaker anesthetic block keep you moving after hip surgery?
- Counting Zzz's after joint surgery: when will you sleep again?
- New study aims to find best pain relief after hip surgery